Does age or gender make a bladder scope more painful? new study aims to find out
NCT ID NCT07375641
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how age and sex influence pain before and after a first-time flexible cystoscopy (a thin tube inserted into the bladder). Researchers will ask 150 adults to rate their expected and actual pain using a simple 0-10 scale. The goal is to better understand who might need extra support during the procedure, helping doctors tailor their approach and reduce anxiety.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and manage pain during cystoscopy, leading to more personalized care and less anxiety for patients.
- What could go wrong
- This is an observational study, not testing a new treatment. Results may not apply to everyone, and pain perception is subjective, so findings might not lead to clear changes in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients (≥18 years) undergoing first-time flexible cystoscopy under local anesthesia in an outpatient setting, with assessment of expected and perceived pain levels
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years * Patients undergoing flexible cystoscopy for the first time under local anesthesia in an outpatient setting * Ability to understand the study procedures and provide informed consent Exclusion Criteria: * Use of systemic analgesics, sedatives, or anxiolytics immediately before the procedure * Presence of active urinary tract infection at the time of cystoscopy * Presence of an indwelling urethral catheter at the time of cystoscopy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign prostate obstruction (BPO) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kayseri Education and Research Hospital
Kayseri, Kocasinan, 38080, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Music and lidocaine timing: a simple recipe for a gentler cystoscopy?
- Can doctors predict which stricture repairs will hold?
- Can a Bladder-Instilled biologic keep recurrent bladder cancer at bay?
- Could a common vitamin restore immunotherapy power after antibiotics?
- Could a simple infusion during surgery stop pain before it starts?
- Could less be more? bladder cancer trial tests stopping immunotherapy after tumors vanish